Roth Capital Affirms BioBlast Pharma (ORPN) at 'Buy'; Sees Trehalose Plan Heading in Right Direction
Go back to Roth Capital Affirms BioBlast Pharma (ORPN) at 'Buy'; Sees Trehalose Plan Heading in Right DirectionOrient Paper, Inc. NEW (NASDAQ: ORPN) | Delayed: 11.50 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $11.50 | 52 Week High | $7.95 | |||
Open | $10.61 | 52 Week Low | $1.36 | |||
Day High | $11.50 | P/E | 21.30 | |||
Day Low | $11.50 | EPS | $0.54 | |||
Volume | 903,889 |